scholarly journals A novel shoulder disability staging system for scapulothoracic arthrodesis in patients with facioscapulohumeral dystrophy

2020 ◽  
Vol 106 (4) ◽  
pp. 701-707
Author(s):  
İlker Eren ◽  
Olgar Birsel ◽  
Özgür Öztop Çakmak ◽  
Ayça Aslanger ◽  
Yasemin Gürsoy Özdemir ◽  
...  
2009 ◽  
Vol 42 (17) ◽  
pp. 22
Author(s):  
BETSY BATES
Keyword(s):  

VASA ◽  
2001 ◽  
Vol 30 (Supplement 58) ◽  
pp. 6-14 ◽  
Author(s):  
Edmonds ◽  
Foster

The diabetic ischaemic foot has become an increasingly frequent problem over the last decade. However, we report a new approach consisting of a basic classification, a simple staging system of the natural history and a treatment plan for each stage, within a multi-disciplinary framework. This approach of "taking control" consists of two parts: 1. long-term conservative care including debridement of ulcers (to obtain wound control), eradication of sepsis (micribiological control), and provision of therapeutic footwear (mechanical control), and 2. revascularisation by angioplasty and arterial bypass (vascular control). This approach has led to a 50% reduction in the rate of major amputations in patients attending with ischaemic ulceration and absent foot pulses from 1989 to 1999 (from 4.6% to 2.3% per year). Patients who underwent angioplasty increased from 6% to 13%. Arterial bypass similarly increased from 3% to 7% of cases. However, even with an increased rate of revascularisation, 80% of patients responded to conservative care alone. This,we conclude, is an essential part of the management of all patients with ischaemic feet.


Praxis ◽  
2016 ◽  
Vol 105 (1) ◽  
pp. 47-52 ◽  
Author(s):  
Andreas Lohri

Zusammenfassung. Maligne Lymphome unterteilen sich zwar in über 60 Entitäten, das grosszellige B-Zell-Lymphom, das follikuläre Lymphom, der Hodgkin und das Mantelzell-Lymphom machen aber mehr als die Hälfte aller Lymphome aus. Im revidierten Ann Arbor staging system gelten die Suffixe «A» und «B» nur noch für den Hodgkin. «E» erscheint nur noch bei Stadien I und II. Eine Knochenmarksuntersuchung wird beim Hodgkin nicht mehr verlangt, beim DLBCL (Diffuse large B cell lymphoma) nur, falls das PET keinen Knochenmark-Befall zeigt. Der PET-Untersuchung, speziell dem Interim-PET, kommt eine entscheidende Bedeutung zu. PET-gesteuerte Therapien führen zu weniger Toxizität. Gezielt wirkende Medikamente mit eindrücklicher Wirksamkeit wurden neu zugelassen. Deren Kosten sind hoch. Eine strahlen- und chemotherapiefreie Behandlung maligner Lymphome wird in Zukunft möglich sein.


2016 ◽  
Vol 54 (05) ◽  
Author(s):  
J Merz ◽  
D Nagel ◽  
P op den Winkel ◽  
S Hempe ◽  
CJ Steib ◽  
...  
Keyword(s):  

2007 ◽  
Vol 34 (S 2) ◽  
Author(s):  
K Traufeller ◽  
K Eger ◽  
J Hobohm ◽  
M Deschauer ◽  
S Zierz

1989 ◽  
Vol 25 (1) ◽  
pp. 52
Author(s):  
J M Lee ◽  
J H Moon ◽  
D J Lee ◽  
C S Choi ◽  
I W Kang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document